DE2212739A1 - Vaccine zur Immunisation gegen Zahncaries - Google Patents

Vaccine zur Immunisation gegen Zahncaries

Info

Publication number
DE2212739A1
DE2212739A1 DE19722212739 DE2212739A DE2212739A1 DE 2212739 A1 DE2212739 A1 DE 2212739A1 DE 19722212739 DE19722212739 DE 19722212739 DE 2212739 A DE2212739 A DE 2212739A DE 2212739 A1 DE2212739 A1 DE 2212739A1
Authority
DE
Germany
Prior art keywords
polyfructosans
strain
vaccine according
streptococcus
germs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19722212739
Other languages
German (de)
English (en)
Inventor
Kestenbaum Richard Charles
Abdul Gaffar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colgate Palmolive Co
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of DE2212739A1 publication Critical patent/DE2212739A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
DE19722212739 1971-03-22 1972-03-16 Vaccine zur Immunisation gegen Zahncaries Pending DE2212739A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12693371A 1971-03-22 1971-03-22

Publications (1)

Publication Number Publication Date
DE2212739A1 true DE2212739A1 (de) 1972-10-05

Family

ID=22427441

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722212739 Pending DE2212739A1 (de) 1971-03-22 1972-03-16 Vaccine zur Immunisation gegen Zahncaries

Country Status (11)

Country Link
JP (1) JPS5549571B1 (enExample)
AT (1) AT320848B (enExample)
AU (1) AU464116B2 (enExample)
BE (1) BE781047A (enExample)
CA (1) CA990646A (enExample)
CH (1) CH562879A5 (enExample)
DE (1) DE2212739A1 (enExample)
ES (1) ES400957A1 (enExample)
FR (1) FR2130412B1 (enExample)
GB (1) GB1343755A (enExample)
ZA (1) ZA721479B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931398A (en) * 1973-06-20 1976-01-06 Colgate-Palmolive Company Method for local immunization against dental caries

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2548848A (en) * 2016-03-30 2017-10-04 The Inst Of Food Res Levan polysaccharide to modulate cell function

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931398A (en) * 1973-06-20 1976-01-06 Colgate-Palmolive Company Method for local immunization against dental caries

Also Published As

Publication number Publication date
ES400957A1 (es) 1975-01-16
AT320848B (de) 1975-02-25
ZA721479B (en) 1973-10-31
CH562879A5 (enExample) 1975-06-13
BE781047A (fr) 1972-07-17
AU3998872A (en) 1973-09-20
FR2130412B1 (enExample) 1976-04-16
FR2130412A1 (enExample) 1972-11-03
GB1343755A (en) 1974-01-16
CA990646A (en) 1976-06-08
JPS5549571B1 (enExample) 1980-12-12
AU464116B2 (en) 1975-07-31

Similar Documents

Publication Publication Date Title
DE3539202C2 (enExample)
DE69329693T2 (de) Verwendung von Bakterienhüllen der Ordnung Beggiatoales oder der Gattung Vitreoscilla als Wirkstoff eines Medikamentes, das für die Anregung der nichtspezifischen Immunität bestimmt ist
DE4447677C2 (de) Verfahren zur Herstellung eines Impfserums zur Immunisierung gegen Pseudomonas Aeruginosa-Infektionen
DE2735411A1 (de) Verfahren zur herstellung von acellulaeren vaccinen und nach diesem verfahren gewonnene vaccine
DE3686158T2 (de) Impfstoff gegen mastitis.
DE3024282A1 (de) Vakzinierende glycopeptid-antigenfraktion mit grosser immunisierungsfaehigkeit, isoliert aus kulturen pathogener keime, verfahren zur isolierung dieser fraktion und diese enthaltende vakzinen
DE2833545A1 (de) Hochmolekulare meningokokken- gruppe c-vaccine und verfahren zu ihrer herstellung
DE69026371T2 (de) Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren
DE2926406A1 (de) Praeparat zur behandlung maligner neoplasien und verfahren zu seiner herstellung
DD202623A5 (de) Verfahren zur herstellung von sporen-polyosiden
DE3541044A1 (de) Neues, allgemein anwendbares antigen (psc-a) gegen pseudomonas aeruginosa, das als mittel zum schutz gegen pseudomonas aeruginosa-infektion wirkt
DE2704766A1 (de) Toxoid-impfstoff gegen pseudomonas aeruginosa-infektionen
DE4324859A1 (de) Oral verabreichbare Zusammensetzung zur Behandlung periodontaler Erkrankungen
DE3427477C2 (enExample)
DE3122669A1 (de) "verfahren zur herstellung von neuen mutanten von herpes simplex-viren typ 1 und typ 2"
DE2212739A1 (de) Vaccine zur Immunisation gegen Zahncaries
CH657989A5 (de) Biologisch aktive substanz, verfahren zur herstellung der substanz, sowie die substanz enthaltende, immunoaktive zusammensetzung.
DE4007315A1 (de) Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen
DE2152112C3 (de) Impfstoff gegen Pseudomonas aeruginosa
DE2829975A1 (de) Antitumor wirksame substanz, deren herstellung und verwendung
DE3504940A1 (de) Multipotente paramunitaetsmediatoren, verfahren zu ihrer herstellung und diese mediatoren enthaltende arzneimittel
DE2737060C2 (de) Escherichia coli-Neurotoxin
DD143729A5 (de) Verfahren zur herstellung eines immunbiotherapeutischen arzneimittels gegen infektionen der atemwege
DE2921829C2 (enExample)
DE1115888B (de) Verfahren zur Herstellung eines Streptokinase-Praeparates